Trial Profile
Effect of elvitegravir and dolutegravir in patients with raltegravir-experienced HIV-1-infection
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Dec 2015
Price :
$35
*
At a glance
- Drugs Dolutegravir (Primary) ; Elvitegravir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 30 Dec 2015 New trial record